Vevorisertib (trihydrochloride), CAS [[1416775-08-0]]

Produktübersicht

• Artikelname: Vevorisertib (trihydrochloride), CAS [[1416775-08-0]]
• Artikelnummer: MCE-HY-137458A
• Hersteller Artikelnummer: HY-137458A
• Alternativnummer: MCE-HY-137458A-10MMX1ML,MCE-HY-137458A-50MG,MCE-HY-137458A-100MG,MCE-HY-137458A-5MG,MCE-HY-137458A-10MG,MCE-HY-137458A-25MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: ARQ 751 (trihydrochloride)

Produktbeschreibung

Vevorisertib (ARQ 751) trihydrochloride is a selective, allosteric, pan-AKT and AKT1-E17K mutant inhibitors. Vevorisertib trihydrochloride potently inhibit phosphorylation of AKT. Vevorisertib trihydrochloride has Kd values of 1.2 nM and 8.6 nM for AKT1 and AKT1-E17K, respectively. Vevorisertib trihydrochloride has IC50 values of 0.55, 0.81, and 1.3 nM for AKT1, AKT2, and AKT3, respectively. Vevorisertib trihydrochloride can be used for the research of cancer[1].

Produkteigenschaften

• Molekulargewicht: 696.11
• Reinheit: 99.13
• CAS Nummer: [1416775-08-0]
• Formel: C35H41Cl3N8O
• Target-Kategorie: Akt

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound1